754312
Last Update Posted: 2022-06-06
Recruiting has ended
Females accepted | 18 Years + |
1 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer
The primary objective of the study is to evaluate changes in the expression of targeted biomarkers in invasive breast cancer tissue before and after SNDX-275 administration.
Eligibility
Relevant conditions:
Breast Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov